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Binding of allosteric effectors to ribonucleotide reductase protein
R1: reduction of active-site cysteines promotes substrate binding
Mathias Eriksson1, Ulla Uhlin1, Ramaswamy S1, Monica Ekberg2, 
Karin Regnström2, Britt-Marie Sjöberg2 and Hans Eklund1*
Background: Ribonucleotide reductase (RNR) is an essential enzyme in DNA
synthesis, catalyzing all de novo synthesis of deoxyribonucleotides. The enzyme
comprises two dimers, termed R1 and R2, and contains the redox active
cysteine residues, Cys462 and Cys225. The reduction of ribonucleotides to
deoxyribonucleotides involves the transfer of free radicals. The pathway for the
radical has previously been suggested from crystallographic results, and is
supported by site-directed mutagenesis studies. Most RNRs are allosterically
regulated through two different nucleotide-binding sites: one site controls
general activity and the other controls substrate specificity. Our aim has been to
crystallographically demonstrate substrate binding and to locate the two
effector-binding sites.
Results: We report here the first crystal structure of RNR R1 in a reduced
form. The structure shows that upon reduction of the redox active cysteines, the
sulfur atom of Cys462 becomes deeply buried. The more accessible Cys225
moves to the former position of Cys462 making room for the substrate. In
addition, the structures of R1 in complexes with effector, effector analog and
effector plus substrate provide information about these binding sites. The
substrate GDP binds in a cleft between two domains with its β-phosphate
bound to the N termini of two helices; the ribose forms hydrogen bonds to
conserved residues. Binding of dTTP at the allosteric substrate specificity site
stabilizes three loops close to the dimer interface and the active site, whereas
the general allosteric binding site is positioned far from the active site.
Conclusions: Binding of substrate at the active site of the enzyme is
structurally regulated in two ways: binding of the correct substrate is regulated
by the binding of allosteric effectors, and binding of the actual substrate occurs
primarily when the active-site cysteines are reduced. One of the loops stabilized
upon binding of dTTP participates in the formation of the substrate-binding site
through direct interaction with the nucleotide base. The general allosteric
effector site, located far from the active site, appears to regulate subunit
interactions within the holoenzyme.
Introduction
Ribonucleotide reductase (RNR) is an essential enzyme
in DNA synthesis that catalyzes all de novo synthesis of
deoxyribonucleotides. The deoxyribonucleotides for DNA
synthesis in a proliferating cell are produced from the
corresponding ribonucleotides by the enzyme ribonu-
cleotide reductase. In higher organisms, and some micro-
organisms like Escherichia coli, this enzyme is a tetramer
with two types of subunits [1]. In these class I reduc-
tases, the holoenzyme is an α2β2 tetramer where α2 is
denoted R1 and β2 is denoted R2. E. coli R1 has a mol-
ecular weight of 171 kDa and R2 a molecular weight of
87 kDa. R1 contains two types of allosteric binding sites
and the active site, while R2 contains a free radical
located on Tyr122, close to a dinuclear iron center. The
reduction of ribonucleotides is initiated by an organic
free radical generated from the R2 subunits. The class I
RNRs require oxygen to generate radicals. Microorgan-
isms other than E. coli have ribonucleotide reductases
which can function in anaerobic environments. The class
II RNRs utilize adenosylcobalamin to generate radicals
in both anaerobic and aerobic surroundings. The class III
RNRs only function in anaerobic conditions and require
AdoMet to create a glycyl radicals.
The three-dimensional structure of the two homodimeric
proteins R1 and R2 have been determined separately
[2,3]. The R1 subunit is composed of three domains: one
mainly helical N-terminal domain of 220 residues; one
ten-stranded α/β-barrel domain of 480 residues; and a
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small 70 residue α+β domain [3,4] (Figure 1). The active
site is located in the center of a deep cleft which runs
across the subunit between the N-terminal and the α/β-
barrel domains. The α/β barrel is composed of two halves,
where each half contains five parallel strands and four reg-
ularly arranged connecting helices. The two halves are
connected in an antiparallel fashion between strands βA
and βF and strands βE and βI. Two cysteine residues are
located on the first of these connections. This cysteine
pair performs the actual reduction of the substrate and is
oxidized during the reaction. The reduction of these active-
site cysteines involves two additional cysteine residues,
located on the flexible C terminus of R1, which appear to
swing out to be reduced by glutaredoxin or thioredoxin
and then swing in to reduce the active-site cysteines [5–7].
The active site is too narrow to allow thioredoxin or glu-
taredoxin to come into direct contact with the active-site
cysteines [3]. The wide α/β barrel allows the insertion of a
finger-like loop into its center with a conserved cysteine
residue, Cys439, on its tip; this residue has been sug-
gested to form a transient radical, abstracting the 3′-hydro-
gen from the ribose ring of the substrate to create a
substrate radical [8,9]. 
Many enzymes at metabolic key points are allosterically
regulated. A common mechanism is that the enzymes are
feed-back regulated by end-products. In the case of RNR,
the enzyme is inhibited by high concentrations of dATP
[1,10]. In contrast, the enzyme needs ATP to be active.
Thus, the relative concentrations of ATP and dATP regu-
late the activity of the enzyme. RNR is further regulated
in a unique way by a second class of allosteric activators
which influence the substrate specificity of the enzyme so
as to obtain a balanced supply of deoxyribonucleotides for
DNA synthesis. Imbalance leads to a higher mutation rate
[11–15]. The substrate specificity is shifted from pyrimi-
dine reduction to the reduction of GDP by binding of
dTTP at the specificity site, and to ADP reduction by the
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Figure 1
The R1 dimer from the dTTP cocrystallized
coordinates with the AMPPNP and GDP
molecules superimposed. The secondary
structure elements are shown in ribbon
representation and colored: the N-terminal
domain is in magenta, the central ten-stranded
α/β-barrel green, α12 and α24 are dark blue,
loops 1 to 3 are drawn in thick lines in cyan at
the dimer interface, the finger loop in the
middle of the barrel is in yellow, the small
domain is in light green and remaining protein
structural fragments are in violet. The
nucleotides are shown in CPK representation:
AMPPNP at the general allosteric (activity or
low-affinity) site is shown in dark blue, dTTP at
the allosteric specificity site is in yellow and
the substrate molecule GDP at the active site
is colored purple. (The figure was generated
with BOBSCRIPT, Robert Esnouf’s extended
version of MOLSCRIPT [61] and was
rendered using RENDER from the
RASTER3D package [62,63].)
binding of dGTP. This series of events has been des-
cribed as a sequential transformation of the substrate
specificity. The binding of nucleotide effectors takes place
at two different sites [1,10]. ATP and dATP bind to the
general activity site, while ATP, dATP, dTTP and dGTP
bind at the substrate specificity site (Figure 1). dATP
binds most strongly  to the substrate specificity site, which
has also been called the high-affinity site. 
We report here crystal structures of RNR R1 which pro-
vide further information about these two sites: one struc-
ture contains dTTP bound to the substrate specificity site
and the other contains the ATP analog AMPPNP bound to
the activity site. The ways in which these two sites regu-
late the enzyme are discussed. Furthermore, in the previ-
ously reported crystallographically determined structures
of R1 the redox active Cys225 and Cys462 residues were
oxidized forming a disulfide bridge [3]. Several crystals
have now been obtained in a reduced form from both wild-
type and mutant proteins. In this paper we describe the
structure of the reduced R1 primarily from the structure of
the reduced mutant Tyr730→Phe (Y730F), because of the
higher resolution obtained for these crystals, although we
have obtained the same results from wild-type crystals. In
addition, a ternary complex with the allosteric regulator
dTTP and the substrate GDP has been investigated. On
the basis of the new structures we suggest a proposal for
the mechanism of substrate reduction.
Results
Binding of dTTP to the specificity site
It has been possible to characterize the binding of dTTP
from wild type R1 crystals cocrystallized with dTTP and
CDP. The active site is in the oxidized form and the sub-
strate molecule, CDP, is not bound. The dTTP binds to
the site which should be the high-affinity site, also called
the substrate specificity site. The location of this site is
consistent with affinity labelling experiments using nucleo-
tides that selectively labelled Cys292 [16]. The binding
site identified by our structure determination is located
close to this residue.
The interaction between the two subunits in the R1 dimer
comprises a four-helix bundle formed by the A and B
helices of the α/β barrel of each subunit; the A and B heli-
ces of one subunit are related by twofold symmetry to the
corresponding helices of the other subunit. The allosteric
substrate specificity effectors bind at the end of these four
helices, across the subunit interface, in such a way that the
phosphates of the effector are located at the N terminus of
helix αA of one subunit, while the base of the nucleotide is
bound close to the C termini of helices αA and αB of the
other subunit. The photoaffinity labelled residue, Cys292,
is located immediately after the end of αB close to the
nucleotide base. The nucleotide effector is bound at each
side of the slim waist of the dimeric molecule (Figure 2a).
This binding is consistent with the observation that prepa-
rations of mouse R1, which have a higher proportion of
monomers than the E. coli R1, dimerize in the presence of
nucleotide effectors [17].
The details of the binding of the allosteric effector dTTP
are shown in Figures 2b–d. The nucleotide is bent with
the γ-phosphate approximately at right angles to the
nucleotide base. The α-phosphate is bound to the amino
end of αA with a hydrogen bond to the mainchain of
residue 234. The γ-phosphate binds to the mainchain of
residue 269 in loop 1, whereas the sidechain of Arg262 in
the same loop also interacts with the γ-phosphate. The
extra density observed around the phosphates may be due
to a Mg2+ ion, as 10 mM Mg2+ is present in the crystalliza-
tion solution. The deoxyribose has 2′-endo conformation;
the 3′-OH of the deoxyribose is hydrogen bonded to
Asp232 just before αA. His275 from loop 1 is close to the
deoxyribose but does not seem to form any hydrogen
bond to it. 
The base of dTTP is inserted into a pocket between the
two subunits and mainly interacts with hydrophobic resi-
dues. The thymine base binds to residues from both sub-
units: Ile268 from loop 1 covers one side of the base while
Leu234, from the same subunit, and Cys292 from the
other subunit interact with the other side of the base. O2
is close to His275 from loop 1 while O4 is close to the car-
bonyl group of Ser249 at the C terminus of αA in the
neighboring molecule.
Stabilization of three loops close to the dimer interface
It was not possible to locate three loops close to the dimer
interface in the electron-density maps of the native
protein [3]. In the complex with the allosteric effector
dTTP, all three loops are visible and thus have defined
positions (Figure 2a). As mentioned above, three of the
residues in loop 1 interact with the effector: Arg262 with
the γ-phosphate, Ile268 with the base and the mainchain
of residue 269 with the γ-phosphate. The latter interaction
cannot be made by a diphosphate; thus the stabilization of
the loop cannot be made by a diphosphate nucleotide.
Loop 2 also interacts with the effector nucleotide and
Cys292 forms hydrophobic contacts with the nucleotide
base. Furthermore, loop 2 is in contact with loop 1 and
loop 3 from the other subunit; the position of one loop
influences the others. 
The allosteric activity site
The allosteric activity site is located on the N-terminal tip
of the R1 protein. In the native data set, the density for
the first 20 N-terminal residues contained several breaks
and the connectivity was not obvious. In more recent
data sets collected from single fresh crystals, these
residues were seen to form a three-stranded mixed β sheet
Research Article  Substrate and effector binding to RNR R1 Eriksson et al. 1079
together with residues 50–54. The first 100 residues of the
N terminus form the allosteric activity site cleft, compris-
ing a four-helix bundle covered by this three-stranded
β sheet (Figure 3a). A wild-type R1 crystal was soaked
with the allosteric effector ATP analog, AMPPNP, and
the substrate CDP. AMPPNP binds deep in the cleft with
the adenine base hydrogen bonded to the mainchain of
residues 17–19 and surrounded by the hydrophobic
residues Val7 and Ile21. The ribose sugar is close to His59.
At the entrance of the cleft, four positively charged
residues, Lys9, Arg10, Lys21 and Lys91 surround the neg-
atively charged phosphates. Thr55 binds to the 5′ oxygen
(Figures 3b and c). The ATP analog should bind to the
allosteric specificity site as well, but there is only weak
density at this site. This might be due to the need for a
structural rearrangement that was impossible during the
one hour soak. There was no density for the substrate
molecule in the oxidized active site. 
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Figure 2
The allosteric substrate specificity site is
occupied by the effector molecule dTTP. (a)
The specificity site is positioned at each side
of the four-helix bundle, forming the dimer
interface of the R1 molecule. The binding of
the dTTP effector molecules leads to a
stabilization primarily of loop 1. The thymine
base of the effector also makes hydrophobic
interactions with loop 2, but it is mainly
through the interactions with loop 1 and
loop 3 from the other subunit that loop 2
becomes positioned. Finally, loop 3 interacts
with loop 3 of the other subunit in the middle
portion of the helices. (b) Stereo drawing of
the allosteric effector dTTP binding site. The
γ-phosphate oxygens bind to the mainchain
nitrogen of residue 269 and to the sidechain
of Arg262. The sidechain is rigidly positioned
via its hydrogen bonds to the mainchain
carbonyl of residue 267 and to the sidechain
of Asp232. Asp232 in turn hydrogen bonds to
the 3′ hydroxyl group of the deoxyribose in
dTTP. The α-phosphate is hydrogen bonded
to the N terminus of the αA helix. The thymine
base is enclosed by hydrophobic residues
with Leu234 on one side of the ring and
Ile268 on the other. All residues except
Cys292 and Ser249 are from the same
subunit. The effector molecule is colored
green, atoms are shown in standard colors
and hydrogen bonds are depicted as red
lines. (c) Schematic drawing of the binding of
the allosteric effector dTTP to the specificity
site. The circles represent the four-helix
bundles making up the dimer interface of the
R1 protein. dTTP is sitting on top of the N
terminus of αA and αB from one subunit a
and the C-terminus of αA and αB from the
other symmetry-related subunit b. The
squared residues represent the hydrophobic
sidechains that interact with the thymine base.
(d) A multiple averaged 2Fo–Fc electron-
density map calculated from model phases
excluding dTTP, contoured at 1σ (ten cycles
with RAVE [54,55]). The final model of dTTP
is superimposed. (Figures a, b and d were
generated with BOBSCRIPT, Robert Esnouf’s
extended version of MOLSCRIPT [61].)
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Reduced R1
The redox active cysteines, Cys225 and Cys462, are posi-
tioned on one wall of the catalytic cleft. Difference den-
sity maps of reduced proteins have prominent differences
close to the former disulfide bridge. In the difference
Fourier between the oxidized and dithiothreitol (DTT)
reduced wild-type crystal data at 3 Å resolution [18],
small changes were observed in the density around Cys225.
The differences are much more pronounced around
Cys462 with a strong negative density positioned on the
sidechain of Cys462 of the oxidized R1, and a strong pos-
itive density beside the mainchain, indicating a sidechain
rotation of Cys462. The differences around the active-
site cysteines for the mutant Y730F protein indicate the
same differences as for the wild-type protein but are
more detailed due to the higher resolution. Similar dif-
ferences are also observed for the Cys225→Ser mutant
(UU, unpublished data).
The structure of the Y730F protein was refined using the
wild-type structure as the initial model [4]. The refined
structure verifies that the mutant protein has a phenyl-
alanine residue in position 730 [19]. The phenylalanine
occupies the same position as the wild-type tyrosine main-
taining the pi–pi interaction between the sidechains of
residues 730–731. The differences are small close to the
phenylalanine residue and probably negligible, suggesting
that the lack of activity of the mutant is due to the loss of
the hydroxyl group and that the hydrogen bond is im-
portant for radical transfer [19]. The redox active cysteine
pair (Cys225 and Cys462) is reduced in the Y730F protein
but the two cysteines are positioned far from the substi-
tuted tyrosine and there is no obvious interaction between
the reduced cysteinyl residues and Phe730.
The refined structure of the reduced protein confirms that
Cys462 changes conformation significantly on reduction
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Figure 3
The overall activity site is occupied by the ATP
analog AMPPNP. (a) The first 100 residues
form a four-helix bundle (α1–α4) covered by a
small mixed β sheet (βI–βIII); AMPPNP binds
in the middle of this cleft. (b) Stereo drawing
showing the binding of AMPPNP. The
adenosine base is stacked upon Val7 on one
side and Ile22 and Ile58 on the other. It also
makes mainchain interactions with residues
16 and 18 in a base-specific manner. His59 is
close to His88 and the ribose 3′-hydroxyl.
Positively charged residues are positioned
around the phosphates. The AMPPNP has
been colored green. (c) A multiple averaged
2Fo–Fc electron-density map calculated from
model phases excluding AMPPNP, contoured
at 0.85σ (ten cycles with RAVE [54,55]). The
final model of AMPPNP is superimposed. (The
figures were generated with BOBSCRIPT,
Robert Esnouf’s extended version of
MOLSCRIPT [61].)
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while the change of Cys225 is more limited (Figures 4a,b).
Cys462 is the most buried of the two redox active cys-
teines and turns around upon reduction, with mainchain
torsions up to 40° (Figure 4b). The sulfur atom of Cys462
changes more than any other atom (6 Å between the two
redox states). Reduction of the active site disulfide bridge
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Figure 4
Structure comparison of the active-site region
of R1 in the oxidized and reduced form. (a)
Final SIGMAA weighted 2Fo–Fc map of the
reduced redox center of the Tyr730→Phe
mutant protein contoured at 1σ. The reduced
structure is shown with bonds colored purple.
An oxidized redox center has been
superimposed with the bonds colored yellow
to show the differences between the two
redox states. The hydrogen bonds that are
cleaved and formed during the reduction
process are colored red. (b) Comparison of
the βF mainchain in the reduced and oxidized
structures. The differences between the
reduced and the oxidized Φ and Ψ angles are
shown for the residues surrounding Cys462.
Coloring as in (a). (c) Stereo drawing showing
the details of the βG, βF and βA strands of
the barrel in the oxidized form; hydrogen
bonds are in red and α17 and the finger loop
in cyan. (d) Stereo drawing showing the
details of the βG, βF and βA of the barrel in
the reduced form; hydrogen bonds in red and
α17 and the finger loop in cyan. (The figures
were generated with BOBSCRIPT, Robert
Esnouf’s extended version of MOLSCRIPT
[61].)
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gives rise to movements of the mainchain of βA and βF
where Cys225 and Cys462 are located. This leads to the
break of a hydrogen bond between the amino group of
Cys225 and the carbonyl of Cys462. The movement of the
Cα of Cys462 is about 2 Å. Smaller movements of neigh-
boring strands are coupled to this change. The reduced
Cys462 and its two neighboring residues move into a hole
between βF, α17 and βG, which is usually filled with
water molecules (Figure 4c). In the reduced form
(Figure 4d), the sulfur atom of Cys462 is pointing away
from Cys225 and is buried in a mainly hydrophobic envi-
ronment composed of Ile442, Val444, Leu464 and Ala618,
but is also hydrogen bonded to the sidechain of Gln691.
Cys225 moves to the former position of Cys462 leading to
a 2.0 Å difference for the sulfur atom. The result of the
disulfide bond breaking is that the sulfur atoms of the
former disulfide bridge are 5.7 Å away from each other in
the reduced state. 
At Cys462 there is a switch in the β-sheet interactions. Up
to residue 462 βF is connected to βA but after residue 462
to βG. This break allows Cys462 to be more flexible. In
the oxidized form, there is a row of water molecules
between residues 461–463 in βF and residues 512–513 in
βG (Figure 4c) leading out to the surface on the rearside of
the protein. In the reduced form, one of these water mol-
ecules disappears and is replaced by the sulfur atom of
Cys462. The solvent channel is probably used to remove
water molecules during reduction, thereby allowing a less
rigid structure.
Binding of substrate
A mutant Cys292→Ala R1 protein crystal was soaked with
DTT, GDP and dTTP. This mutant has a higher affinity
for GDP than the wild-type protein [20] (KR and B-MS,
unpublished data), and responds to allosteric regulation at
4°C (KR and B-MS, unpublished data), whereas the wild-
type protein lacks allosteric regulation at 4°C. The mole-
cule has a low occupancy probably due to the competition
from sulfate ions for the β-phosphate binding site of the
substrate. With the help of averaged densities it was
possible to model-build a substrate (Figure 5a), however,
the present map excludes a detailed interpretation of the
substrate base position. 
The binding of substrate occurs roughly as predicted from
modeling studies [3]. GDP binds at the active site with
the diphosphates farthest into the active-site cleft
(Figure 5b). The β-phosphate binds at the N terminus of
helices α12 and α24, forming hydrogen bonds with the
mainchain nitrogens of residues 623 and 624 at the N ter-
minus of helix α24 (Figure 5c). The sidechains of Thr624
and Ser625 of helix α24 form hydrogen bonds to β-phos-
phate oxygens. There are no hydrogen bonds from any
mainchain nitrogen atoms of α12 to the phosphates and the
hydrogen bonding possibilities are limited due to Pro210 at
the N-terminal end of this helix. The only hydrogen bond
from α12 is formed between the sidechain of Thr209 and
one of the β-phosphate oxygens. The α-phosphate forms
no hydrogen bonds with the protein. 
The ribose ring is positioned with Cys439 on one side and
Cys225–Cys462 on the other side at the 2′ corner. The 3′-
oxygen is hydrogen bonded to the sidechain of Glu441,
while the 2′-oxygen atom is hydrogen bonded to the
sidechains of Asn437 and Cys225 (Figures 5c,d). Cys439,
Glu441 and Asn437 are located on the tip of the loop that
is inserted into the center of the α/β barrel. Cys462 is posi-
tioned far from the ribose ring (Figure 5d). Cys439 is in
van der Waals contact with the 3′-carbon atom and is in an
excellent position for removing the 3′-hydrogen, as sug-
gested in the mechanism of action of the enzyme [7]. 
The nucleotide base of the substrate is only partly visible
in our structure, but is close to strand βB and the end of
loop 2 (beginning of βC). Strand βB contains a Gly-Ile-Gly
motif that is to some extent conserved. The first of these
glycines is almost always present in R1 sequences; the
absence of a sidechain leaves space for the nucleotide base
of the substrate.
The reduced cysteines occupy the same positions as in the
other reduced structures. Comparison of the ribose-binding
site in the reduced R1 and the oxidized structure shows
that Cys225 would restrict substrate binding to the oxi-
dized form of the enzyme (Figure 5d). The sulfur atom of
this residue would be only 1.7 Å away from the 2′-oxygen
in the oxidized form. The binding of a ribose ring is thus
prevented by steric hindrance when the active site thiols
are in their disulfide form.
Discussion
Reduction of R1
RNR catalyzes the reduction of ribonucleotides to deoxy-
ribonucleotides by means of two active-site cysteine resi-
dues, Cys225 and Cys462. We have now determined the
three-dimensional structure of the reduced R1 protein
which shows that Cys462 undergoes a local conformational
change: it moves about 6 Å and is positioned deep into the
protein, being even less accessible than in the oxidized
form. Cys225 moves less and the largest difference
between the two oxidation states is a movement by the
sulfur atom of 2.0 Å .
Redox active thiol proteins usually have sequentially close
cysteine residues intervened by only two or four residues
[21,22]. The reduction of thioredoxins, glutaredoxins, thio-
redoxin reductase and glutathione reductase, all proteins
with sequentially close redox active cysteine residues,
results in minor conformational changes where the cysteine
residues just move their sulfur atoms apart by sidechain tor-
sions [23–28]. The conformational change in R1 is much
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larger than those observed for the other redox active pro-
teins and includes mainchain movements (Figure 4b). The
requirement of a large conformational change may be a way
of avoiding accidental oxidation of the active site.
Ribonucleotide reduction also involves the participation
of free radicals. In the resting enzyme, a free radical is
stored in the interior of the R2 protein close to a dinu-
clear iron center. The structure determination of RNR
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Figure 5
The substrate-binding pocket is occupied by
the substrate molecule GDP. (a) A multiple
averaged 2Fo–Fc electron-density map
calculated from model phases excluding
nucleotides, contoured at 0.7σ (ten cycles
with RAVE [54,55]). The final model of GDP
is superimposed. (b) The substrate-binding
cleft with the substrate molecule GDP (shown
in ball-and-stick representation). The
phosphates are firmly fixed to the N-terminal
ends of the helices α12 and α24. The loop
finger in the middle of the barrel is colored
yellow and residue Cys439 is located close to
the ribose of the substrate. (c) Stereo view of
the substrate binding to the active site;
hydrogen bonds are indicated with red lines.
The β-phosphate binds to the mainchain
nitrogens of residues 623 and 624 in the N
terminus of helix α24. The sidechains of
Thr624 and Ser625 (of α24) and Thr209 (of
α12) also bind to the β-phosphate oxygen
atoms. The ribose hydroxyl groups are
hydrogen bonded to Glu441, Cys225 and
Asn437. The sidechain carbonyl group of the
latter residue hydrogen bonds to two
mainchain nitrogens. The proposed radical
transfer chain is indicated via dashed magenta
lines from Tyr731, Tyr730, Cys439 and finally
to the ribose carbons C2′. (d) The substrate-
binding structure is colored with purple bonds
showing the binding of the ribose at the active
site of R1. The 3′-oxygen is hydrogen bonded
to the sidechain of Glu441, while the 2′-
oxygen atom is hydrogen bonded to the
sidechain of Asn437. The oxidized structure
(yellow) of the 2.5 Å structure has been
overlaid. The distances between the sulfur
atoms of cysteines 225, 439 and 462 to the
substrate are given in Å for the reduced form
and modeled for the oxidized form. The
position of Cys225 in the oxidized form would
hinder substrate binding. (The figures were
generated with BOBSCRIPT, Robert Esnouf’s
extended version of MOLSCRIPT [61].)
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has led to the suggestion that there exists a specific
radical transfer pathway between the tyrosyl radical of
R2 and the active site in R1 [2,3,19,29–32]. This pathway
has been suggested to occur between Tyr122 in R2 via
the iron center and its ligands, and the R2 residues
Asp237, Trp48, Tyr356 and via the R1 residues Tyr731,
Tyr730, Cys439 and the ribose substrate. The picture
emerges that one of the important roles of the enzyme is
to control the release of the oxidizing power of the free
radical of Tyr122 in R2 to generate a transient radical at
the active site in R1. Only when the substrate is in place
should the radical transfer process be initiated so that no
harmful side reactions occur.
For these reasons, we believe that it is important that R1
is in a reduced form when the substrate binds. If the sub-
strate were to bind to the active site of oxidized R1 and a
radical form at the ribose substrate, the reaction could
not go to completion as the substrate could not be re-
duced by an active-site disulfide. Studies of substrate
analogs and mutants have demonstrated that if the reac-
tion is not completed, destruction of the substrate and
the enzyme itself can occur as a result of misdirected
radical reactions [33–37]. Mutation of one of the redox
active cysteines, Cys225→Ser, allows formation of a sub-
strate radical, but, as the reaction is not completed, a
breakdown of the substrate occurs with release of the
base and the phosphate moiety [38]. A transient peptide
radical is formed at the site of the mutation which results
in the subsequent cleavage of the R1 polypeptide chain
[39]. As the radical of R2 was consumed in the reaction,
the Cys225→Ser mutation destroyed both R1, R2 and
the substrate [7,38]. A similar series of reactions might
occur if the substrate could bind efficiently to an active
site in the oxidized state. The initial part of the reaction
would generate a substrate radical but, since the reaction
could not be completed, it could destroy the enzyme.
Such events must be avoided and a favorable binding
site for the substrate should be present only in the
reduced form. Mechanism studies show that the inactiva-
tion by the inhibitor 2′-chloro-2′-deoxyuridine 5′-diphos-
phate is ten times slower when the enzyme is in its
oxidized state compared to the reduced state [40]. The
most probable explanation is the decreased binding
affinity due to Cys225 in the oxidized state.
This hypothesis is supported by the fact that we have
never succeeded in binding substrate to an oxidized
enzyme. No substrate was bound to the active site in the
oxidized enzyme cocrystallized with dTTP and substrate,
nor did it bind in other complexes that were oxidized. The
reduction of the active-site disulfide results in an altered
topography of the active site; the redox active cysteines
move away from the proposed ribose-binding site in the
reduced state. This explains the failure to bind the sub-
strate in the oxidized form of the protein. 
Substrate specificity
The specificity of RNR for nucleoside diphosphates is
achieved by the narrow internal phosphate-binding site.
A nucleoside triphosphate cannot bind at the substrate
site with its ribose positioned close to the active-site
cysteines. Likewise, a mononucleotide cannot bind in an
active conformation at the active site because there are
no interactions with the α-phosphate of the GDP sub-
strate. Ribose should bind more efficiently than deoxyri-
bose in reduced R1 because of the hydrogen bonds to
the 2′-oxygen from Asn437 and Cys225. On the other
hand, deoxyribose nucleotides might still bind to the
active site after the reduction as the main close contact
with the oxidized disulfide would be via the 2′-oxygen of
the ribose.
Nucleotide effector specificity in the allosteric substrate
specificity site
Our structural studies suggest that only a triphosphate
nucleoside bound to the high-affinity substrate speci-
ficity site between the two R1 subunits can have an
effect on the activity. The binding of the mainchain NH
of residue 269 in loop 1 and Arg262 to the γ-phosphate is
important in this respect. The binding of the deoxyri-
bose of the effector includes an important hydrogen
bond from the 3′-oxygen atom to Asp232. This binding
site is crowded and the binding of a ribonucleotide at
this site is not excluded but should be less favorable and
lead to structural rearrangements. These structural ob-
servations offer a plausible explanation for the several
orders of magnitude worse binding of ATP as compared
to dNTPs to this site [20,41,42]. The binding of the base
affects neighboring loops and the interactions with loop 2
are probably influenced by the size of the base of the
effector.
The allosteric regulation of substrate specificity
The distance between the binding site of dTTP and the
closest binding site of the substrate is about 15 Å (Fig-
ure 2a). The distance between the effector and substrate
nucleotides is, therefore, too long to allow direct interac-
tions between them. The effect of the allosteric effector
must be mediated through protein interactions. The im-
portant mediators in this signal transduction appear to be
loop 1 and loop 2, which are unordered in the absence of
effector but are visible in the presence of effector; pri-
marily loop 1 is affected. The important interactions that
the allosteric effector nucleotide makes with loop 1 are
the hydrophobic interactions between Ile268 and the
base, and the hydrogen bond between the mainchain nitro-
gen of residue 269 and the γ-phosphate. Similar types of
interactions have also been observed in G proteins. For
the α subunit of the transducin trimeric G protein [43],
changes in one of the switch regions are initiated by a
hydrogen bond between the peptide NH of Gly199 and
the γ-phosphate of GTP. 
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Loop 2 interacts with the effector nucleotide via Cys292
and the position of this loop is affected by the base of the
effector and by the position of loop 1. In addition, loop 2
can interact with the base of the substrate. In the dTTP
structure, there are only weak interactions between the
base of the effector and loop 2. However, the binding of
protein R2 in the holoenzyme complex could influence
the position of the loops as they are located at the pro-
posed R1–R2 interaction area. It may be that the final
position of the loops are not established until the holoen-
zyme complex has been formed.
Alignment of the available R1 sequences (Figure 6) shows
that residues involved in the binding of the allosteric
effector nucleotide are to a high degree conserved within
those enzymes which are allosterically regulated. The
herpes virus group of enzymes, which are not allosteri-
cally regulated, lack this conservation and the important
loop 2 appears to be missing completely in these se-
quences. The loop 2 sequences are particularly con-
served in the allosterically regulated enzymes. The
Asp232 and Arg262 that are essential for the binding of
sugar and phosphate are conserved, as well as the base
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A comparison of R1 amino acid sequences for the areas involved in
binding the allosteric effector dTTP. Sequences for αA, αB, loop 1 and
loop 2 are included. The E. coli numbering is marked below the
secondary structure motifs (shown in light purple ). The fully conserved
residues are colored yellow and those more than 80% conserved are
colored dark green. Residues fully conserved in the presumed
allosterically regulated enzymes are colored light green. The red
triangles mark residues interacting with dTTP. (Sequence alignments
were done manually using the DNASTAR subprogram Megalign as an
editor. The alignments were formated using ALSCRIPT [64].)
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A comparison of R1 sequences of the first 100 residues involved in
binding at the overall activity site. The E. coli numbering is marked
below the secondary structure motifs shown in red, while the human
(and mouse) numbering is shown above the human sequence. The
class 1b sequences have been excluded because they lack this region.
The herpes virus group shows no conservation in this region and is
also omitted. Yellow colored residues are fully conserved, light green
12/13 are conserved and dark green 10–11/13 are conserved. Red
triangles mark residues involved in, or close to, the overall allosteric
effector analog AMPPNP. (Sequence alignments were done manually
using the DNASTAR subprogram Megalign as an editor. The
alignments were formated using ALSCRIPT [64].)
interacting residue Ile268. Other residues interacting
with the base (234, 281 and 292) maintain the same
chemical character in different species. Three glycines
(277, 296 and 300) are also conserved allowing for a high
flexibility to accommodate allosteric regulation. Gln294
is conserved but its function in allosteric regulation
remains to be elucidated.
The allosteric overall activity effector site
The allosteric activity site is positioned far away from the
substrate-binding site and the allosteric specificity site
(Figure 1). The N-terminal tip of R1 has one face towards
the postulated R2 binding side of the R1 dimer [3]. The
AMPPNP is bound on the other side of the domain not
facing the R2 side. The binding of AMPPNP does not
lead to any significant conformational change. This might
result from the experimental conditions used, which
involved only a one hour soak at 4°C. There could be a
need for movements in the structure to improve the
binding of the effector that are not seen in this structure.
Experiments with longer soaking times or cocrystallization
of ATP, AMPPNP or dATP have not been successful,
possibly due to the need for a conformational change that
disrupts or prevent the formation of the crystal lattice. 
The overall activity effector probably influences the rela-
tive positions of the two dimeric proteins R1 and R2 and
thus positions residues of the radical pathway in the R1R2
complex, either by a shift in the interaction between R1
and R2 or via a more local change. In the R1R2 model, the
C-terminal part of the R2 protein is closest to the R1 activ-
ity effector site indicating a possible region for regulation. 
Enzymes missing negative inhibition by dATP differ in the
AMPPNP-binding region from those that have this type of
regulation. A group of bacterial class I enzymes called class
1b enzymes all lack the first 50 residues in their R1 pro-
teins; these enzymes do not have negative allosteric regula-
tion and no overall activity site regulation [44]. Likewise, a
mouse R1 mutant, which has lost its negative inhibition by
dATP, has been identified. The mutant is Asp57→Asn,
which corresponds to the ribose interacting, His59 in E. coli
(Figure 7). The T4 enzyme (also lacking the negative
overall allosteric control) has a glutamine residue in the cor-
responding position. His59 hydrogen bonds to His88. This
hydrogen bond appears to be conserved among eukaryotes,
where the His88 has been replaced by an asparagine and
His59 by aspartic acid. The His/Asn88 is accessible from
the front side of the R1 subunit and could be involved in
the R1R2 interaction. Sequence comparisons also indicate
that the proteins from the malarial parasite Plasmodium falci-
parum and African swine fever virus probably lack or have
significant differences in their functional allosteric activity
site (Figure 7). African swine fever virus is truncated in the
N terminus and P. falciparum lacks two of the positively
charged residues (Lys9 is substituted by asparagine and
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Figure 8
Accessible surface plots of the R1 dimer. The surface was generated
with the program GRASP [65] using the coordinates of the cocrystallized
dTTP molecule, without the dTTP. The coordinates of AMPPNP and
GDP have been superimposed on this model and are shown together
with dTTP as stick models. (a) The ‘front face’ of the R1 molecule, which
is suggested [3] to be the binding site for R2. GDP is deeply buried at
the bottom of the catalytic cleft. The two effectors have limited access
from this side. (b) The ‘back side’ of the dimer. The dTTP binding to the
allosteric specificity site has easy access to the solvent and binds at
both sides of the dimer interface. The overall activity site, occupied by
AMPPNP, is also open to the solvent at the two tips of the molecule.
Lys21 by glutamine, in E. coli numbering). The only signif-
icant homology between class Ia and the anaerobic class III
RNRs is in the N-terminal domain. The conservation coin-
cides very well with the AMPPNP interacting residues
(Figure 7) indicating similar ways of regulation between the
two classes.
Accessibility of the effector sites
Both effector sites have easy access to the solvent, even in
the postulated R1R2 complex. If the pools of effector mol-
ecules are changed there is no obvious need for a major
rearrangement of the R1R2 complex in order to change nuc-
leotides. Both sites are probably in close contact with R2 but
their solvent accessibility is not seriously affected by the
R1R2 interaction, as they open towards the non-R2 inter-
acting side of R1 (Figure 8). The enzyme can thereby easily
adapt its ribonucleotide reduction to the needs of the cell.
The catalytic mechanism
The oxidized, the reduced and the reduced GDP-bound
structures of R1 give some new insights into the reaction
mechanism (Figure 9). It is reasonable to assume that the
1088 Structure 1997, Vol 5 No 8
Figure 9
C3 C2
C4 C1
O O
H H
SC439
H
HO
O N
N437E441
H
S
C225
H
H
C3 C2
C4 C1
O O
H
SC439
H
HO
O N
N437E441
H
S
C225
H
H
H
C3 C2
C4 C1
O
H
SC439
H
O
O N
N437E441
H
S C225
H
H
O
N
C462
HS
H
C3 C2
C4 C1
O
H
SC439
H
O
O N
N437E441
H
S C225
H
H
C462
SH
C3 C2
C4 C1
O
H
SC439
H
O
O N
N437E441
H
S C225
H
H
C462
SH
C3 C2
C4 C1
O
H
SC439
H
O
O N
N437E441
H
S C225
H
H
C462
S
H
C3 C2
C4 C1
O
H
SC439
H
O
O N
N437E441
H
S C225
H
H
C462
S
H
C3 C2
C4 C1
O
H
SC439
H
O
O N
N437E441
H
S C225
H
H
C462
S
H
C3 C2
C4 C1
O
H
SC439
H
O
O N
N437E441
H
S C225
H
H
C462
S
H
3
a
b
c
1
-H2O
4b
5a 5b6
7
2
4a
A proposed catalytic mechanism in view of the structures reported here (see text for details).
structure with a reduced active site closely mimics the situ-
ation in the first steps of the reaction, while the structure
with an oxidized state resembles the final steps of catalysis.
A detailed proposal for the mechanism of action of RNR
has been developed during the past decade and a descrip-
tion is depicted in [7]. Cys439 has been suggested to be the
residue at the active site directly responsible for the genera-
tion of a transient radical on the ribose of the substrate. The
first step in the proposed mechanism is a hydrogen atom
abstraction at the 3′-position of the ribose by a thiyl radical
at Cys439 (step 1). The positioning of Cys439 is consistent
with its suggested role in the reaction mechanism as it is in
van der Waals contact with the 3′-hydrogen of the substrate
ribose (Figure 5d). The removal of the 3′-hydrogen is fol-
lowed by a protonation of the 2′-hydroxyl (step 2), which
may be achieved by Cys225, hydrogen bonding to O2′.
Such a protonation facilitates leaving of the 2′-hydroxyl [7].
The next step (step 3) requires a conformational change of
the redox center in order to bring the distant Cys462 to the
active site. A weak hydrogen bond between Cys225 and
Asn437 brings Cys225 closer to the substrate which may
lead to a rotation of the mainchain establishing a hydrogen
bond between the carbonyl of Cys225 and the mainchain
nitrogen of Cys462. The movement may be propagated and
the hydrogen bond forces βF to rotate and bring Cys462 to
the active site. The hydrogen atom of the redox center
could now attack the single electron on C2′ of the substrate
(step 4a) [7]. The last electron to be delivered, however,
cannot go straight to the substrate. The closely located sp3
hybridized C2′ cannot accept any more electrons. Rotating
the sidechain of Cys225 both in the reduced and oxidized
structure shows that the closest distance to O3′ or C3′ of the
substrate would be over 4 Å. Instead, Cys225 (both in the
reduced and oxidized structure) can by these sidechain
rotations readily make a hydrogen bond with the sidechain
amide nitrogen of Asn437. We propose that the electron
instead passes through Asn437 and Glu441 to O3′ and C3′
(step 6). On the other hand, this pathway could be used
even in the first electron transfer from the redox center
(step 4b). The sulfur would loose its negative charge and
the substrate its radical. The formed C2′ carbanion would
easily abstract a proton from Cys225/462 in the next step
(step 5). The reduction of ribose would, therefore, utilize
two transfer pathways. One for protons (steps 2 and 5a) be-
tween Cys225 and O2′/C2′ of the substrate, while electrons
(steps 4b and 6) would be transferred from the redox pair
through Asn437 and Glu441 to O3′ and C3′ of the substrate.
The only purely radical chemistry would be the C3′ hydro-
gen abstraction and addition.
Biological implications
Ribonucleotide reductase (RNR) catalyzes all de novo
synthesis of deoxyribonucleotides and is thus an essential
enzyme in DNA synthesis during cell proliferation. RNR
is an allosteric enzyme regulated by nucleoside triphos-
phates. ATP is a general positive allosteric regulator,
while dATP in high concentrations acts as a negative
feedback regulator. Furthermore, nucleotides also act as
allosteric activators to regulate substrate specificity of the
enzyme, so as to obtain a balanced supply of deoxyri-
bonucleotides for DNA synthesis. Imbalance leads to
mutator phenotypes. 
We have now localized the allosteric binding sites by crys-
tallographic investigations. The holoenzyme is an α2β2
tetramer, where α2 is termed R1 and β2 R2. The ATP
analogue AMPPNP binds to the N-terminal domain of
the RNR R1 protein. This binding site is located far from
the active site and its function is suggested to optimize the
interactions between the homodimeric R1 and R2 pro-
teins. The allosteric substrate specificity effector, dTTP,
binds to a second allosteric site at the dimer interface
between the two R1 subunits. The binding of this effector
stabilizes three loops that are highly flexible in the wild-
type protein. The effector cannot directly influence the
binding of the substrate but can affect substrate binding
indirectly by the positioning of these loops.
The substrate GDP binds to R1 primarily when the
redox active-site cysteines are reduced. When the active-
site cysteines form a disulfide bridge, the binding site
cannot allow the 2′-hydroxyl of the substrate to be
bound in the same conformation as in the reduced en-
zyme. The β-phosphate of the substrate penetrates
deep into the active-site cleft and interacts with the 
N termini of two helices. This site is too small to allow
nucleoside triphosphates to bind.
The regulation that we describe is particularly important
for the enzyme which uses free radicals to transform the
substrate. The translocation of the radicals via an approx-
imately 30 Å long transfer chain, between a buried posi-
tion on Tyr122 inside the R2 protein and the substrate
ribose in the active site of R1, has to be properly regu-
lated. Unwanted radical reactions can otherwise occur
with disasterous effects. The restrictions of the active site
to allow a substrate to bind selectively to the reduced
form protect the enzyme from the generation of a radical
at the substrate ribose in the absence of reducing power.
Such radical reactions in enzymes with mutationally
altered redox active cysteines have previously been
shown to destruct both substrate and enzyme. The allo-
steric effectors appear to regulate the relative orientation
between the R1 and R2 proteins, which probably affects
the radical transfer pathway.
Materials and methods
Purification and crystallization of R1 protein
Wild-type and mutant R1 were purified from overproducing strains
[19,45–47] (KR and B-MS, unpublished data) according to the proce-
dure described by Uhlin et al. [48]. During preparation of the Y730F
mutant, the purification procedure was changed slightly and before the
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final elution step with distilled water from the phenylsepharose column,
the column was washed with 0.05 M Tris buffer, pH 7.6. The crystals
were obtained in hanging drops (5 ml protein mixture + 5 ml reservoir
solution). The protein mixture contained 17 mg/ml R1 protein and a 20-
fold excess of a 20-residue peptide corresponding to the C terminus of
the R2 subunit. This peptide is essential for the crystallization and has
the same conformation in all the studies described in this paper as in
the original structure determination [3]. In the cocrystallization experi-
ments dTTP and CDP were added, 30 min prior to setting up the
hanging drops, to a final concentration of 10 mM each. The reservoir
contained 17% Li2SO4 and 10 mM MgSO4 in 25 mM citrate buffer at
pH 6.0. The mutant and nucleotide-containing R1 proteins were crys-
tallized in the same space group, R32, as the wild-type protein with
three subunits in the asymmetric unit [48]. GDP, AMPPNP and DTT
were dissolved at 100–200 mM concentrations in the same solution as
the reservoir. dTTP was purchased from Pharmacia Biotech in 100 mM
stock solutions; 0.5 ml of these solutions were added to the drops con-
taining the crystals. Final concentrations and soaking times are shown
in Table 1. To reduce the crystals, DTT was added together with the
nucleotides in the dTTP/GDP soak to a final concentration of 10 mM. 
Data collection
Cryocooling of crystals was achieved by rapidly transferring the crystals
from the hanging drop through a cryo-solution containing 11–15% eth-
ylene glycol, 17% Li2SO4, 25 mM citrate buffer at pH 6.0 and the same
nucleotide concentrations as in the soaking solution. These crystals
have smaller cell dimensions: a = b = 224 Å and c = 334 Å compared to
non-frozen R1 protein crystals with cell axes a = b = 227 Å and
c = 341 Å. Data were collected either at the home source rotating
anode Rigaku on a RAXIS2 detector, Hamburg EMBL outstation station
X31 on a small MAR, or at Brookhaven National Laboratory X12b on a
MAR detector. Data were indexed with DENZO, scaled and reduced
with SCALEPACK [49] and truncated with programs from the CCP4
suite [50]. Details of the different data sets are summarized in Table 1.
Phasing
The protein coordinates (with waters excluded) of unliganded wild-type
E. coli R1 RNR collected at 8°C to 2.5 Å, [4] were used as a starting
model for determining the phases of a mutant (Glu441®Ala) data set
collected at cryogenic temperature to 2.9 Å. TNT [51] was first used
for rigid-body refinement, firstly, with all three subunits together as one
rigid body leading to a drop of R from 52% to 47%. Then each of the
three subunits was treated as one rigid body leading to a further drop
of R to 30%. This worked despite differences in cell dimensions of up
to 2%. The refined data of that mutant was used for phasing of the
other data sets collected at cryogenic temperature (data 3 and 4)
using the same rigid-body refinement procedure with typical drops of R
from 35% to 31% during the first rigid-body refinement and further
down to about 28% during the second. The data sets collected at tem-
peratures above 0°C (data 1 and 2) used the coordinates of the 2.5 Å
structure as their starting model giving similar statistics. 
Model building and refinement
The models were initially refined with TNT using strict noncrystallo-
graphic symmetry (NCS). During the final refinement REFMAC [50]
was used with restrained NCS. The noncrystallographic correlation
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Table 1
Crystallographic data collection and refinement statistics.
Parameters Data 1 Data 2 Data 3 Data 4
Protein Y730F wild type wild type C292A
Reduced/Oxidized Reduced Oxidized Oxidized Reduced
Nucleotides and/or DTT dTTP(10), AMPPNP(20), dTTP(10),   
(final concentration in mM) - CDP(10) CDP(20) GDP(10), 
DTT(10)
Soaking time - Cocrystallized 1 h 48 h
substrate site - - - GDP*
specificity site - dTTP - dTTP
activity site - - AMPPNP -
Data collection location† EMBL X31 Daresbury 9.6 BNL X12B Home/Rigaku
Temperature (K) 278 283 100 100
Resolution (Å) 30–2.9 20–3.0 30–3.0 30–3.2
I/σ 15.6 12.3 13.5 9.5
Total completeness (%) 96.0 83.0 96.1 97.2
Rsym 8.7 9.5 12.1 9.6
Final shell 3.0–2.9 3.1–3.0 3.1–3.00 3.4–3.2
Completeness (% >2σ) 52.2 45.2 42.7 52.2
Rsym 37.3 34 35 31
Refinement
protein atoms 17 977 17 804 17 921 17 963
ligand atoms 0 82 93 171
solvent atoms 312 0 84 0
R value 22.7 25.1 25.5 26.7
Rfree 24.8 28.8 29.4 31.1
Rms deviations from ideality
bond lengths (Å) 0.007 0.009 0.015 0.012
bond angles (°) 1.7 2.2 3.0 2.6
*Occupancy 0.5. †EMBL X31 is the DESY synchrotron in Hamburg, at
EMBL station X31 collected on a small MAR (18 cm). Daresbury 9.6 is
the Daresbury synchrotron station 9.6 collected on a RAXIS detector.
BNL X12B is the Brookhaven National Laboratory station X12B on a
big MAR (30 cm). Home/Rigaku is the Rigaku rotating anode collected
on a RAXIS2c detector.
was maintained by using only one of the three molecules in the manual
model building in O [52] and generating the other two via the NCS. 
Residues surrounding regions where positive densities in Fo–Fc maps
indicated nucleotide binding were deleted or mutated to alanine
residues. After refinement with REFMAC, SIGMAA weighted maps
[53] were calculated and then used as starting maps for RAVE [54,55]
for multiple averaging. These maps could be used for manual model
building in O of the dTTP molecule in the specificity site and loop 1 and
2 in data 2. These parts were fully visible except for some of the
sidechains of the loops and even the puckering of the sugar ring of
dTTP could be determined to have a 2′-endo conformation. The loops
were less visible in the ternary complex (data 4) but the dTTP molecule
could be built in, however, in the case of the substrate molecule GDP
we had to accept a lower occupancy that was finally set to 0.5. An ATP
molecule could easily be built into the activity site (data 3). Sidechains
of the proposed phosphate-binding residues (Lys9, Arg10, Lys21 and
Lys91) are disordered probably due to a multiple conformation of the
triphosphate orientation. XPLOR and O parameter files were generated
with XPLO2D and MOLEMAN2 respectively (GJ Kleywegt, Uppsala
university, Sweden). XPLO2D generated an energy-minimization rou-
tine for XPLOR [56] that was used during the manual rebuilding to reg-
ularize the nucleotides. REFMAC parameter files were generated with
the CCP4 program MAKEDICT [50]. Parameter files for dTTP were
generated from the PDB coordinates of dTDP in nucleoside diphos-
phate kinase determined to 2.0 Å (1ndc) [57], the γ-phosphate was
manually added from CTP in aspartate transcarbomoylase at 2.5 Å
(1raa) [58]. GDP was taken from transducin–αGDP–AIF4– determined
to 1.7 Å (1tad) [59]. An ATP molecule was used for building in the
AMPPNP from casein kinase-1 determined to 2.0 Å (1csn) [60]. Final
statistics of the refined structures are shown in Table 1.
Accession numbers
The atomic coordinates have been deposited with the Protein Data
Bank. The accession codes are 1R1R (data 1, Y730F mutant with
reduced active site), 2R1R (data 2, wild type with bound dTTP and oxi-
dized active site), 3R1R (data 3, wild-type with bound AMPPNP and
oxidized active site) and 4R1R (data 4, C292A mutant with bound
GDP and dTTP, and reduced active site).
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